Abstract
The Epstein-Barr virus (EBV) is a lymphotropic herpes virus with oncogenetic properties which can lead to the development of lymphomas such as Burkitt's lymphoma (BL), Hodgkin's lymphoma (HL), or post-transplant lymphoma. This review discusses our current understanding of lymphomagenesis in relation to EBV and the potential for targeted therapies.
Original language | English |
---|---|
Pages (from-to) | 348-353 |
Number of pages | 6 |
Journal | Cancer Treatment Reviews |
Volume | 36 |
Issue number | 4 |
Early online date | 2 Mar 2010 |
DOIs | |
Publication status | Published - 1 Jun 2010 |